 |
|
LIAI launches new division to look at novel approaches to heart disease and inflammation
September 30, 2008While cholesterol-lowering drugs and new technologies have significantly advanced the nation's battle against heart disease, it continues to rank as the No. 1 killer of U.S. men and women. But if researchers at the La Jolla Institute for Allergy & Immunology (LIAI) have their way, the body's immune system will become an important player in reducing heart disease.
"The statins (cholesterol-lowering drugs) have taken a big chunk out of the numbers of people who suffer from heart disease and heart attacks," said Klaus Ley, M.D., director of the Institute's recently launched Inflammation Biology Division. "We hope we can bite off another chunk by controlling the impact of inflammation-causing immune cells on the artery wall."
Mitchell Kronenberg, Ph.D., LIAI president & scientific director, said the Institute recruited Dr. Ley, one of the leading research experts in the field, to head the new division. "We are excited to have a scientist of Dr. Ley's stature lead our new Inflammation Biology Division," he said. "Its creation puts us in a very select group of immunology institutions worldwide that are exploring new ways of fighting heart disease using the immense power of the immune system."
Ley said the immune system's role in heart disease is a relatively recent finding, with the first inklings of its importance discovered in the early 1980s. Prior to that time, scientists believed that atherosclerosis, a blockage in the arteries and the underlying cause of most heart problems, was due to plaque formation caused solely by cholesterol buildup. "The scientific community used to think cholesterol alone led to plaque formation," Ley explained. "While it is true that cholesterol plays a major role, it is not the whole story."
Ley, an internationally recognized scientist who helped pioneer the scientific discipline of vascular immunology, which looks at novel immune-based approaches to heart disease, said inflammation caused by the immune system is also an important participant in plaque formation and weakening of the artery wall. As such, it offers a whole new therapeutic avenue for potential ways to combat heart disease.
Prior to joining the Institute, Ley was director of the Robert M. Berne Cardiovascular Research Center at the University of Virginia, where he oversaw the efforts of the Center's faculty while also conducting his own research program. Ley was recently selected as the 2008 recipient of the prestigious Marie T. Bonazinga Research Award from the Society for Leukocyte Biology. Ley will receive the award in November in recognition for his work illuminating the basic cellular mechanisms underlying inflammation, particularly as it relates to heart disease.
Mark Ginsberg, M.D., a distinguished professor of medicine at UC San Diego and member of the University's new Institute of Engineering in Medicine, which Ley recently joined as an adjunct faculty member, said he is delighted to welcome someone of Ley's achievements as a colleague.
"Klaus' extraordinary contributions to our understanding of inflammation in the vessel wall are a superb complement to existing strengths at UCSD in biomedical engineering, vessel wall biology and other areas related to cardiovascular disease," said Ginsberg, a prominent vascular biology researcher. "LIAI has shown great vision in recruiting Klaus to lead a program to bridge immunology to cardiovascular disease."
In the 1980s, Ley said immunology's role in heart disease first came to light when immunology researchers found that plaque buildup in the arteries also contained inflammation-causing T cells of the immune system. "This opened up the possibility that the inflammatory process was important in heart disease," said Ley. Further study found that inflammatory T cells not only contributed to plaque formation, but they also played a key role in the rupture of the artery wall, which produces a heart attack.
It is this aspect of the inflammatory process that draws Ley's primary attention. He focuses on macrophages, white blood cells of the immune system that usually rid the body of worn-out cells. However, in the case of the artery wall, the macrophages take on a destructive role, exacerbating the weakening of the artery wall caused by plaque formation. "The macrophages switch on a very specific program that we are trying to understand and to decipher why it weakens, rather than heals, the artery wall," said Ley, noting that the macrophages weaken the wall to the point of rupturing, which produces a heart attack. "We believe if we can stop that process, we can stop the rupture," said Ley. "This would have major implications for combating heart disease."
Kronenberg said Ley's work holds great promise. "Up to now, it has been under appreciated how important different types of white blood (immune) cells are in contributing to the leading killer of Americans," said Kronenberg. "Klaus (Ley) is a pioneer whose work is showing that the immune system plays a central role in heart disease."
La Jolla Institute for Allergy and Immunology
Ley said the immune system's role in heart disease is a relatively recent finding, with the first inklings of its importance discovered in the early 1980s. Prior to that time, scientists believed that atherosclerosis, a blockage in the arteries and the underlying cause of most heart problems, was due to plaque formation caused solely by cholesterol buildup. "The scientific community used to think cholesterol alone led to plaque formation," Ley explained. "While it is true that cholesterol plays a major role, it is not the whole story."
Ley, an internationally recognized scientist who helped pioneer the scientific discipline of vascular immunology, which looks at novel immune-based approaches to heart disease, said inflammation caused by the immune system is also an important participant in plaque formation and weakening of the artery wall. As such, it offers a whole new therapeutic avenue for potential ways to combat heart disease.
Prior to joining the Institute, Ley was director of the Robert M. Berne Cardiovascular Research Center at the University of Virginia, where he oversaw the efforts of the Center's faculty while also conducting his own research program. Ley was recently selected as the 2008 recipient of the prestigious Marie T. Bonazinga Research Award from the Society for Leukocyte Biology. Ley will receive the award in November in recognition for his work illuminating the basic cellular mechanisms underlying inflammation, particularly as it relates to heart disease.
Mark Ginsberg, M.D., a distinguished professor of medicine at UC San Diego and member of the University's new Institute of Engineering in Medicine, which Ley recently joined as an adjunct faculty member, said he is delighted to welcome someone of Ley's achievements as a colleague.
"Klaus' extraordinary contributions to our understanding of inflammation in the vessel wall are a superb complement to existing strengths at UCSD in biomedical engineering, vessel wall biology and other areas related to cardiovascular disease," said Ginsberg, a prominent vascular biology researcher. "LIAI has shown great vision in recruiting Klaus to lead a program to bridge immunology to cardiovascular disease."
In the 1980s, Ley said immunology's role in heart disease first came to light when immunology researchers found that plaque buildup in the arteries also contained inflammation-causing T cells of the immune system. "This opened up the possibility that the inflammatory process was important in heart disease," said Ley. Further study found that inflammatory T cells not only contributed to plaque formation, but they also played a key role in the rupture of the artery wall, which produces a heart attack.
It is this aspect of the inflammatory process that draws Ley's primary attention. He focuses on macrophages, white blood cells of the immune system that usually rid the body of worn-out cells. However, in the case of the artery wall, the macrophages take on a destructive role, exacerbating the weakening of the artery wall caused by plaque formation. "The macrophages switch on a very specific program that we are trying to understand and to decipher why it weakens, rather than heals, the artery wall," said Ley, noting that the macrophages weaken the wall to the point of rupturing, which produces a heart attack. "We believe if we can stop that process, we can stop the rupture," said Ley. "This would have major implications for combating heart disease."
Kronenberg said Ley's work holds great promise. "Up to now, it has been under appreciated how important different types of white blood (immune) cells are in contributing to the leading killer of Americans," said Kronenberg. "Klaus (Ley) is a pioneer whose work is showing that the immune system plays a central role in heart disease."
La Jolla Institute for Allergy and Immunology
Heart Disease Current Events and Heart Disease News RSSTraditional Risk Assessment Tools Do Not Accurately Predict Coronary Heart Disease
The Framingham and National Cholesterol Education Program tools, NCEP, do not accurately predict coronary heart disease, according to a study performed at the Yale University School of Medicine in New Haven, CT.
Researchers engineer pancreatic cell transplants to evade immune response
In a finding that could significantly influence the way type 1 diabetes is treated, researchers at Albert Einstein College of Medicine of Yeshiva University have developed a technique for transplanting insulin-producing pancreatic cells that causes only a minimal immune response in recipients.
Safe new therapy for genetic heart disease
A new clinical trial suggests that long-term use of candesartan, a drug currently used to treat hypertension, may significantly reduce the symptoms of genetic heart disease.
Simple Model Predicts Those at Risk for Chronic Kidney Disease
Traditionally, doctors have had no clear way to predict which of their patients might be headed down the road to chronic kidney disease (CKD).
Eating at buffets plus not exercising equals obesity in rural America
In small towns in the Midwestern United States, people who eat out often at buffets and cafeterias and who perceive their community to be unpleasant for physical activity are more likely to be obese.
Researchers compile 'molecular manual' for 100s of inherited diseases
An international research team has compiled the first catalogue of tissue-specific pathologies underlying hundreds of inherited diseases.
Patients with severe psoriasis need evaluation of heart disease risk
According to new recommendations in the December 10 issue of The American Journal of Cardiology (AJC), published by Elsevier, new research is called for and patients with severe forms of the skin disease psoriasis should receive evaluation and possible treatment to reduce their risk of coronary artery disease (CAD).
Rare disease provides clues about enzyme role in arrhythmias
A University of Iowa study provides insight into a calcium-sensing enzyme already known to play a role in irregular heartbeats and other critical functions.
Cellular 'brakes' may slow memory process in aging brains
University of Florida researchers may have discovered why some brain cells necessary for healthy memory can survive old age or disease, while similar cells hardly a hairsbreadth away die.
Gene therapy effective treatment against gum disease
Scientists at the University of Michigan have shown that gene therapy can be used to successfully stop the development of periodontal disease, the leading cause of tooth loss in adults.
More Heart Disease Current Events and Heart Disease News Articles
 | Pathophysiology of Heart Disease: A Collaborative Project of Medical Students and Faculty (PATHOPHYSIOLOGY OF HEART DISEASE (LILLY)) Completely rewritten and updated for its Fourth Edition, this best-selling text is a comprehensive, clear, concise, and easy-to-understand introduction to cardiovascular diseases. It is written by internationally recognized Harvard Medical School faculty and select medical students, and is the best text to bridge basic physiology with clinical care of patients. This edition provides updated... |
 | NO More Heart Disease: How Nitric Oxide Can Prevent--Even Reverse--Heart Disease and Strokes by Louis Ignarro Dr. Louis Ignarro discovered "the atom" of cardiovascular health--a tiny molecule called Nitric Oxide. NO, as it is known by chemists, is a signaling molecule produced by the body, and is a vasodilator that helps control blood flow to every part of the body. Dr. Ignarro's findings led to the development of Viagra. Nitric Oxide has a beneficial effect on the cardiovascular system as well.NO... |
 | Prevent and Reverse Heart Disease: The Revolutionary, Scientifically Proven, Nutrition-Based Cure by Caldwell B. Esselstyn A powerful call for a paradigm shift in heart disease therapy. Based on the groundbreaking results of a twenty-year nutritional study by Dr. Esselstyn, a preeminent researcher and clinician, this book illustrates that a plant-based, oil-free diet can not only prevent and stop the progression of heart disease but can also reverse its effects. The proof lies in the incredible outcomes for patients... |
 | Reverse Heart Disease Now: Stop Deadly Cardiovascular Plaque Before It's Too Late by Sinatra, James C., M.D. Roberts While most books focus solely on the role of cholesterol in heart disease, Reverse Heart Disease Now draws on new research that points to the surprising other causes. Two leading cardiologists draw on their collective fifty years of clinical cardiology research to show you how to combine the benefits of modern medicine, over-the-counter vitamins and supplements, and simple lifestyle changes to... |
 | Dr. Dean Ornish's Program for Reversing Heart Disease by Dr Dean Ornish Dr. Dean Ornish was the first person to offer scientific proof that heart disease often can be halted or even reversed simply by changing your diet and lifestyle. Based on his internationally acclaimed scientific studies, Dr. Ornish's program yielded amazing results. Participants often reduced or discontinued medications; their chest pains usually diminished or disappeared; they felt more... |
 | Reversing Heart Disease: A Vital New Program to Help Prevent, Treat, and Eliminate Cardiac Problems Without Surgery by Julian M. Whitaker Here is an update of the complete guide to cardiac carepacked with new ways to conquer heart disease without drugs or bypass surgery! Hundreds of thousands of heart patients have used Dr. Julian Whitakers best-selling Reversing Heart Disease to successfully deal with cardiac problems naturally. Now, drawing on nearly 20 years of experience at his Whitaker Wellness Institute, Dr. Whitaker examines... |
 | Moss and Adams' Heart Disease in Infants, Children and Adolescents: Including the Fetus and Young Adult, 2 Volume Set Established since 1968 as a classic pediatric cardiology text, this two-volume work is now in its Seventh Edition. Leading international experts describe state-of-the-art diagnostic and interventional techniques for young patients with congenital and acquired heart diseases and for adult survivors of congenital heart disease. This edition's section on pediatric cardiac intensive care has new... |
 | The No Bull Book on Heart Disease: Real Answers to Winning Back Your Heart and Health by Joel Okner, Jeremy Clorfene Written in plain English by a board-certified cardiologist and a clinical psychologist who specializes in heart disease, this is a practical “what-to-expect” guide that will help readers cope with their confusion, fear, and lack of information, as well as decode what doctors really mean when they describe certain cardiac procedures, treatments, and medications. The authors clearly explain... |
| Dr. Dean Ornish's Program for Reversing Heart Disease by Dr. Dean Ornish | |
 | Congenital Heart Disease in Adults (Congenital Heart Disease in Adults (Perloff/Child)) by Joseph K. Perloff, John S. Child, Jamil Aboulhosn Dr. Perloff, the founding father of the field of adult congenital heart disease, presents a decade's worth of research and clinical data in the completely redefined 3rd edition to bring you the most current information. With advances in diagnosis and treatment in children, more and more of those with CHD survive well into adulthood. Expert contributors in various fields offer a... |
| © 2009 BrightSurf.com |